Fund Name

$ Value

% Port.

COM NEW

COMMON

$ Bought

% Increased

% Reduced

$ Sold

Shares

Percent

Date

Type

% Portfolio

% Chg

$ Change

$ Held

# Shares

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United State...

Datesorted ascending	Fund Name	Type	% Portfolio	% Chg	$ Change	$ Held	# Shares
2024-05-15	CITADEL ADVISORS LLC	REDUCED	Premium	Premium	Premium	Premium	19,853
2024-05-15	Tower Research Capital LLC (TRC)	ADDED	Premium	Premium	Premium	Premium	7,175
2024-05-15	SABBY MANAGEMENT, LLC	ADDED	Premium	Premium	Premium	Premium	187,293
2024-05-15	ARMISTICE CAPITAL, LLC	ADDED	Premium	Premium	Premium	Premium	176,000
2024-05-13	RENAISSANCE TECHNOLOGIES LLC	NEW	Premium	Premium	Premium	Premium	17,100
2024-05-13	XTX Topco Ltd	NEW	Premium	Premium	Premium	Premium	10,534
2024-05-10	JPMORGAN CHASE & CO	SOLD OFF	Premium	Premium	Premium	Premium	-
2024-05-10	OSAIC HOLDINGS, INC.	UNCHANGED	Premium	Premium	Premium	Premium	25.00
2024-05-10	WELLS FARGO & COMPANY/MN	ADDED	Premium	Premium	Premium	Premium	10.00
2024-05-01	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	SOLD OFF	Premium	Premium	Premium	Premium	-
2024-02-14	Coppell Advisory Solutions LLC	SOLD OFF	Premium	Premium	Premium	Premium	-

Fund Name	# Shares	$ Value	% Port.
SABBY MANAGEMENT, LLC	187,293	150,359,000	0.09%
ARMISTICE CAPITAL, LLC	176,000	141,293	-
CITADEL ADVISORS LLC	19,853	15,878	-
RENAISSANCE TECHNOLOGIES LLC	17,100	14,000	-
XTX Topco Ltd	10,534	8,425	-
Tower Research Capital LLC (TRC)	7,175	5,762	-
OSAIC HOLDINGS, INC.	25.00	20.00	-
WELLS FARGO & COMPANY/MN	10.00	8.00	-
Coppell Advisory Solutions LLC	-	-	-
CONCOURSE FINANCIAL GROUP SECURITIES, INC.	-	-	-

Fund Name	$ Value	% Port.
SABBY MANAGEMENT, LLC	150,359,000	0.09%
Coppell Advisory Solutions LLC	-	-
CONCOURSE FINANCIAL GROUP SECURITIES, INC.	-	-
JPMORGAN CHASE & CO	-	-
OSAIC HOLDINGS, INC.	20.00	-
WELLS FARGO & COMPANY/MN	8.00	-
RENAISSANCE TECHNOLOGIES LLC	14,000	-
XTX Topco Ltd	8,425	-
CITADEL ADVISORS LLC	15,878	-
Tower Research Capital LLC (TRC)	5,762	-

Fund Name	$ Bought
RENAISSANCE TECHNOLOGIES LLC	14,000
XTX Topco Ltd	8,425

Fund Name	% Increased
ARMISTICE CAPITAL, LLC	626
Tower Research Capital LLC (TRC)	120
WELLS FARGO & COMPANY/MN	66.67
SABBY MANAGEMENT, LLC	24.92

BJDX - Bluejay Diagnostics, Inc. Stock Price, Fair Value and News

Which funds bought or sold BJDX recently?

Which funds are the top buyers of BJDX?

Which funds have put a big percent of portfolio in BJDX?

Trend of No. of funds that hold BJDX

Changes in Positions

Investor Breakout

Investor Churn (# Increased Holdings)

New Buys

Additions

Reductions

Sold off

Fund Name	$ Sold
JPMORGAN CHASE & CO	-74.00
CONCOURSE FINANCIAL GROUP SECURITIES, INC.	-
Coppell Advisory Solutions LLC	-674